Passer au contenu principal

Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.

Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinion

Elsevier
Publier avec nous
20th Vaccine Congress

Participate

Submit abstract

Abstracts are now invited on the following topics. They should be submitted using the online abstract submission system.

Abstract Submission Deadline: 30 April 2026

Submit abstract(S’ouvre dans une nouvelle fenêtre)

Conference Topics

  • Systems vaccinology and AI

  • Vaccines against STIs

  • Models for vaccine development and evaluation

  • Pediatric vaccines

  • Therapeutic cancer vaccines

  • Social and political impacts of vaccination and vaccine policy

  • Vaccines against respiratory pathogens

  • One health vaccines

  • Vaccine safety

  • Vaccines for older adults and strategies to tackle immunosenescence

  • Vaccine, adjuvant and delivery technologies

  • Vector borne diseases

  • European vaccine development

  • Veterinary Vaccines

You can submit as many abstracts to the conference for review as you would like.  If, after the review by the committee, you have more than one paper accepted for the conference, you will need to register to attend and pay an additional paper fee for each additional paper (i.e., for the 2nd, 3rd, 4th papers – not the 1st). Please note this is for papers that you are the presenting author of, not papers that you are co-author of.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.

Award Winners

Schneerson Robbins Award

Nominations are now closed

Previous recipients of the award:

  • 2025: Mario Feldman, Washington University, St. Louis, USA

  • 2024: Galit Alter Moderna, USA

  • 2023: Maria Elena Bottazzi, Baylor College of Medicine, USA

  • 2022: Rino Rappuoli, GlaxoSmithKline Vaccines, Italy

  • 2019: Kathryn M. Edwards, Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA

  • 2018: Carol J. Baker, University of Texas Health Science Center, USA

  • 2017: Rachel Schneerson, National Institutes of Health, USA

Jenner Award Winner

  • Rebecca Cox, University of Bergen, Norway

Previous recipients of the award:

  • 2025: Kanta Subbarao, Université Laval, Canada

  • 2024: Kathleen Neuzil, Fogarty International Center, NIH, USA

  • 2023: Robin Shattock, Imperial College London, UK

  • 2022: Myron Levin, University of Colorado, USA

  • 2019: Rino Rappuoli, Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA

  • 2018: Stanley A. Plotkin, University of Pennsylvania & Vaxconsult, USA

  • 2017: John B Robbins, National Institutes of Health, USA

Early Career Researcher Award Winner

  • Young Chan Kim, University of Oxford, UK

Previous recipients of the award:

  • 2025: Marios Koutsakos, The Peter Doherty Institute for Infection and Immunity, Australia

  • 2024: David Martinez, Yale University School of Medicine, USA

  • 2022: Daniela Weiskopf, La Jolla Institute for Immunology, USA

Host Country Early Career Researcher Award Winner

  • Eduard Puente-Massaguer, Icahn School of Medicine at Mount Sinai, USA